Radiation Therapy Approaches for People With Prostate Cancer
Recruiting now · Phase 2
Conditions studied: Prostate Cancer Patients, Non-metastatic Prostate Cancer, High Risk Prostate Cancer
In brief
The purpose of the study is to explore the best ways of giving radiation therapy to balance cancer control and treatment side effects.
Key facts
- Study ID
- NCT07751159
- Run by
- Memorial Sloan Kettering Cancer Center
- People needed
- 126
- Starts
- 2026-07-31
- Expected to finish
- 2030-07-31
- Last updated by the study team
- 2026-08-07
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Non-metastatic prostate cancer.
- Classified as unfavorable intermediate-, high-, or very high-risk prostate cancer according to NCCN risk stratification guidelines. (Note: cT3a or T3b by MRI or PSMA PET allowed)
- Considered by the treating radiation oncologist as a suitable candidate for both HDR brachytherapy boost and SBRT (see clinical considerations for treatment eligibility below)
You may not qualify if…
- None
Where it is running
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey, United States (enrolling)
- Memorial Sloan Kettering at Monmouth (Limited Protocol Activities) — Middletown, New Jersey, United States (enrolling)
- Memorial Sloan Kettering at Bergen (Limited Protocol Activities) — Montvale, New Jersey, United States (enrolling)
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities) — Commack, New York, United States (enrolling)
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities) — Harrison, New York, United States (enrolling)
- Memorial Sloan Kettering Cancer Center (All Protocol Activites) — New York, New York, United States (enrolling)
- Memorial Sloan Kettering at Nassau (Limited Protocol Activities) — Uniondale, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.